Peter Thiel-backed Lindus Health has raised $55 million as it sets about "fixing the broken clinical trial industry." ...

Royal Wolverhampton NHS Trust (RWT), the home of the NIHR West Midlands Regional Research Delivery Network, was to host the ...

The design for a medical study in 1743 that was never carried out may have inspired James Lind’s groundbreaking clinical ...

Use of decentralized approach in a Phase 1 pharmacokinetic trial shows the ability to enable remote data collection and ...

The results of a clinical trial led by researchers at the University of Arizona Health Sciences and published in the Journal ...

GAITHERSBURG, Md., Jan. 21, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage ...

FLC is a rare liver cancer with unique genetic traits, often misdiagnosed until advanced. New research and a clinical trial ...

Following the recent IDE Approval by the U.S. Food and Drug Administration (FDA) for MagicTouch PTA, this enrolment heralds ...

The ocular hypertension market is growing due to the rising prevalence of conditions impairing aqueous humor outflow, such as scarring and inflammation, leading to elevated intraocular pressure (IOP).

Sanford Health is teaming up with Medtronic to test a procedure aimed at reducing medication dependency for high blood ...

Clinical trials form the backbone of medical advancements, driving innovations that improve lives. However, managing these ...

We ran a Q&A With Michael Young, co-founder of Lindus Health on the challenges of 2024 and the company’s goals for 2025.